Open Access

Clinical and molecular study of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency

  • Authors:
    • Mei Deng
    • Man Mao
    • Li Guo
    • Feng‑Ping Chen
    • Wang-Rong Wen
    • Yuan‑Zong Song
  • View Affiliations

  • Published online on: September 27, 2016     https://doi.org/10.3892/etm.2016.3752
  • Pages: 3294-3300
  • Copyright: © Deng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The human solute carrier family 10 member 1 (SLC10A1) gene encodes sodium taurocholate cotransporting polypeptide (NTCP), the principal transporter of conjugated bile salts from the plasma into hepatocytes. Although the function of NTCP has been studied extensively and a number of SLC10A1 variations have been identified in humans, information regarding NTCP deficiency is limited. To date, only one patient with NTCP deficiency has been described; however, in the present study a pediatric patient who experienced intractable and striking hypercholanemia is presented. Analysis of the SLC10A1 gene in the patient revealed a homozygous p.Ser267Phe (c.800C>T) variation, which proved to be a single‑nucleotide polymorphism (SNP) in the allele frequency of 4.7% of healthy controls. This variation involved a conserved amino acid residue on the orthologous alignment that was predicted to be ̔disease‑causing̓ by functional analysis using a number of bioinformatic tools. Next generation sequencing was performed; however, no other genetic causes were identified that would affect the bile acid homeostasis in the patient. Moreover, an adult, with the same genotype as the pediatric patient, was identified for the first time as experiencing mild hypercholanemia. The molecular and clinical findings in the present study suggest, for the first time, that there is an association between p.Ser267Phe SNP and hypercholanemia, and this information may be used to clinically identify NTCP deficiency worldwide.
View Figures
View References

Related Articles

Journal Cover

November-2016
Volume 12 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Deng M, Mao M, Guo L, Chen FP, Wen W and Song YZ: Clinical and molecular study of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency. Exp Ther Med 12: 3294-3300, 2016
APA
Deng, M., Mao, M., Guo, L., Chen, F., Wen, W., & Song, Y. (2016). Clinical and molecular study of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency. Experimental and Therapeutic Medicine, 12, 3294-3300. https://doi.org/10.3892/etm.2016.3752
MLA
Deng, M., Mao, M., Guo, L., Chen, F., Wen, W., Song, Y."Clinical and molecular study of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency". Experimental and Therapeutic Medicine 12.5 (2016): 3294-3300.
Chicago
Deng, M., Mao, M., Guo, L., Chen, F., Wen, W., Song, Y."Clinical and molecular study of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency". Experimental and Therapeutic Medicine 12, no. 5 (2016): 3294-3300. https://doi.org/10.3892/etm.2016.3752